Lyell Immunopharma Inc (LYEL)
0.9478
+0.03
(+3.40%)
USD |
NASDAQ |
Nov 22, 16:00
0.9478
0.00 (0.00%)
After-Hours: 18:18
Lyell Immunopharma Market Cap: 264.65M for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 255.93M |
| November 20, 2024 | 287.60M |
| November 19, 2024 | 309.93M |
| November 18, 2024 | 309.93M |
| November 15, 2024 | 307.14M |
| November 14, 2024 | 307.14M |
| November 13, 2024 | 307.14M |
| November 12, 2024 | 325.29M |
| November 11, 2024 | 337.86M |
| November 08, 2024 | 340.65M |
| November 07, 2024 | 340.65M |
| November 06, 2024 | 413.25M |
| November 05, 2024 | 346.23M |
| November 04, 2024 | 325.87M |
| November 01, 2024 | 287.38M |
| October 31, 2024 | 246.41M |
| October 30, 2024 | 220.23M |
| October 29, 2024 | 243.28M |
| October 28, 2024 | 240.17M |
| October 25, 2024 | 237.86M |
| October 24, 2024 | 279.69M |
| October 23, 2024 | 295.08M |
| October 22, 2024 | 295.05M |
| October 21, 2024 | 287.35M |
| October 18, 2024 | 300.18M |
| Date | Value |
|---|---|
| October 17, 2024 | 302.75M |
| October 16, 2024 | 320.70M |
| October 15, 2024 | 300.18M |
| October 14, 2024 | 305.31M |
| October 11, 2024 | 302.75M |
| October 10, 2024 | 279.65M |
| October 09, 2024 | 277.09M |
| October 08, 2024 | 289.92M |
| October 07, 2024 | 289.92M |
| October 04, 2024 | 313.01M |
| October 03, 2024 | 305.31M |
| October 02, 2024 | 315.57M |
| October 01, 2024 | 328.40M |
| September 30, 2024 | 354.06M |
| September 27, 2024 | 386.56M |
| September 26, 2024 | 389.12M |
| September 25, 2024 | 345.60M |
| September 24, 2024 | 373.76M |
| September 23, 2024 | 366.08M |
| September 20, 2024 | 386.56M |
| September 19, 2024 | 399.36M |
| September 18, 2024 | 345.60M |
| September 17, 2024 | 355.84M |
| September 16, 2024 | 317.44M |
| September 13, 2024 | 314.88M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
220.23M
Minimum
Oct 30 2024
4.297B
Maximum
Sep 10 2021
1.215B
Average
766.48M
Median
Market Cap Benchmarks
| Chimerix Inc | 81.55M |
| NovaBay Pharmaceuticals Inc | 3.349M |
| Palatin Technologies Inc | 18.74M |
| iBio Inc | 24.15M |
| Theriva Biologics Inc | 3.589M |
Market Cap Related Metrics
| PS Ratio | 3831.67 |
| PEG Ratio | -0.3039 |
| Price to Book Value | 0.4987 |
| Price | 0.9478 |
| Earnings Yield | -83.35% |
| PEGY Ratio | -0.3039 |